
Progentec: Pioneering next-gen diagnostics and digital biomarkers for enhanced autoimmune disease care.
Progentec Diagnostics, founded with the mission to revolutionize autoimmune disease care, focuses on developing next-generation diagnostics and digital biomarkers. The company aims to transform the management of autoimmune diseases such as lupus and multiple sclerosis through innovative blood-based tests and digital health tools. Their flagship products include the aiSLE® DX Flare Risk Index and aiSLE® DX Disease Activity Index, which are available through Mayo Clinic Laboratories. Progentec’s market focus is on providing advanced diagnostic solutions to healthcare providers and patients for proactive disease management.
Notable affiliations include partnerships with Mayo Clinic Laboratories, enhancing the credibility and reach of their diagnostic tests. Progentec has achieved significant milestones, including the successful launch of their aiSLE™ MGMT platform, which integrates proteomics and digital health insights for better disease management. The company’s impact is evident in its contribution to improving patient outcomes and enabling more personalized care for those with autoimmune conditions. Through their pioneering work, Progentec is setting new standards in the diagnostics industry.

Exagen
exagen.com

Probius
probius.bio

Diogenix
diogenix.com
Proteogenix
PLC Diagnostics

Proactive Diagnostics
pro-dx.com

Predictive Health Diagnostics Company

Chosen Diagnostics

Applied Proteomics

C2N Diagnostics
c2n.com

PrognomiQ
prognomiq.com

SynapDx

Proxim Diagnostics
proximdx.com

Techcyte
techcyte.com

Sera Prognostics
Companies similar to Progentec Diagnostics include Exagen, Probius, Diogenix and Proteogenix.
Progentec Diagnostics was founded in 2015.
Progentec Diagnostics' headquarters is located in Oklahoma City, OK, US.
Progentec Diagnostics' most recent funding round was for $5M (USD) in January 2020.
As of Jan 9, 2020, Progentec Diagnostics has disclosed funding of $6.3M (USD). Undisclosed round amounts are excluded.
Progentec Diagnostics has 14 employees as of Feb 5, 2024.